Q2 STOCKS TO BUY

Stocks Mixed After Job Openings, Consumer Data

The Fed's two-day policy meeting is starting today

Deputy Editor
Jul 30, 2024 at 12:01 PM
facebook X logo linkedin


Stocks are mixed midday, as the Federal Reserve's two-day policy meeting gets underway, with plenty of earnings and economic data for Wall Street to unpack in the meantime. The consumer confidence index rose to 100.3 in July from June's 97.8, though elevated prices remain a concern, while June job openings totaled 8.18 million -- down from the upwardly revised 8.23 million in May. The hiring rate, excluding Covid times, hit its highest level in almost 11 years. 

At last glance, the Nasdaq Composite Index (IXIC) is down triple digits, while the S&P 500 Index (SPX) sits lower as well. The Dow Jones Industrial Average (DJIA), though paring earlier gains, is still firmly higher. 

Continue reading for more on today's market, including:

  • 2 pharma stocks to watch after earnings. 
  • Mixed report dents Procter & Gamble stock
  • Plus, call traders eye TLRY; JBLU heads for best day in four years; and NVAX plummets on downgrade. 

mmc july30

Options bulls are targeting Tilray Brands Inc (NASDAQ:TLRY), which is up 11.3% at $2.03 at last glance after the company beat fiscal fourth-quarter revenue expectations. So far, 129,000 calls have been exchanged -- nine times the amount typically seen at this point -- in comparison to just 9,613 puts. The weekly 8/2 2-strike call is the most popular by far. The equity has been in penny stock territory for a couple years now, and is still down 11.5% year to date. 

JetBlue Airways Corp (NASDAQ:JBLU) is up 22% at $7.23 at last glance, after the airline name's strong second-quarter results. The company also announced it was delaying buying $3 billion worth of airbus planes. Headed for its best day since its March 2020, JBLU is up 30.5% year to date. 

jblu july30

Novavax Inc (NASDAQ:NVAX) stock is down 24.6% at $12.38 and on the short sell restricted (SSR) list today, after J.P. Morgan Securities downgraded it to "underweight" with an $8 price target. Year to date, the biotech stock is still up roughly 156%. 

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter